Pacific Biosciences Of California | PACB - Los Gastos De Explotación





Los Gastos De Explotación Cambio Fecha
Agilent USD 1.44B 9M 2026-03
Bruker USD 768.9M 44.3M 2026-06
Danaher USD 52.58B 368M 2026-06
General Electric Aerospace USD 17.64B 417M 2026-06
Illumina USD 899M 47M 2026-06
Myriad Genetics USD 212.8M 16.2M 2025-12
Pacific Biosciences Of California USD 97.83M 41.29M 2025-12
Quidel USD 646.2M 1.21B 2026-06
Revvity USD 603.55M 24.8M 2026-06
Roche Holding CHF 18.9B 2.12B 2026-06
Standard Biotools USD 30.56M 15.16M 2026-03
Thermo Fisher Scientific USD 9.81B 716M 2026-06
Waters USD 527M 592M 2026-06